{"doi":"10.1093/neuonc/noab282","title":"Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making","abstract":"BACKGROUND: Targeted gene NGS testing is available through many academic institutions and commercial entities and is increasingly incorporated in practice guidelines for glioblastoma (GBM). This single-center retrospective study aimed to evaluate the clinical utility of incorporating NGS results in the management of GBM patients at a clinical trials-focused academic center. METHODS: We identified 1011 consecutive adult patients with pathologically confirmed GBM (IDHwt or IDHmut) who had somatic tumor sequencing (Oncopanel, ~500 cancer gene panel) at DFCI from 2013-2019. Clinical records of all IDHwt GBM patients were reviewed to capture clinical trial enrollment and off-label targeted therapy use based on NGS results. RESULTS: Of the 557 IDHwt GBM patients with sequencing, 182 entered clinical trials at diagnosis (32.7%) and 213 (38.2%) entered after recurrence. Sequencing results for 130 patients (23.3%) were utilized for clinical trial enrollment for either targeted therapy indications (6.9 % upfront and 27.7% at recurrent clinical trials and 3.1% for off-label targeted therapy) or exploratory studies (55.4% upfront and 6.9% recurrent clinical trials). Median overall survival was 20.1 months with no survival difference seen between patients enrolled in clinical trials compared to those who were not, in a posthoc analysis. CONCLUSIONS: While NGS testing has become essential for improved molecular diagnostics, our study illustrates that targeted gene panels remain underutilized for selecting therapy in GBM-IDHwt. Targeted therapy and clinical trial design remain to be improved to help leverage the potential of NGS in clinical care.","journal":"Neuro-Oncology","year":2021,"id":168967,"datarank":0.515098080672772,"base_score":3.4339872044851463,"endowment":3.4339872044851463,"self_citation_contribution":0.515098080672772,"citation_network_contribution":0.0,"self_endowment_contribution":0.515098080672772,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":30,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.8343,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2021-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":699934,"name":"Gilbert C Youssef","orcid":null,"position":1,"is_corresponding":false},{"id":580521,"name":"Mehdi Touat","orcid":"0000-0002-5910-7799","position":2,"is_corresponding":false},{"id":89706,"name":"J. Bryan Iorgulescu","orcid":"0000-0003-1405-3667","position":3,"is_corresponding":false},{"id":699143,"name":"Sydney Whorral","orcid":"0009-0002-3861-6444","position":4,"is_corresponding":false},{"id":699144,"name":"Marie Allen","orcid":"0009-0005-9917-1751","position":5,"is_corresponding":false},{"id":642613,"name":"Rifaquat Rahman","orcid":"0000-0002-9443-1797","position":6,"is_corresponding":false},{"id":492423,"name":"Ugonma Chukwueke","orcid":"0000-0003-0598-9535","position":7,"is_corresponding":false},{"id":270985,"name":"J Ricardo McFaline-Figueroa","orcid":"0000-0002-6670-1841","position":8,"is_corresponding":false},{"id":238090,"name":"Lakshmi Nayak","orcid":"0000-0003-2725-8717","position":9,"is_corresponding":false},{"id":428967,"name":"Eudocia Q. Lee","orcid":"0000-0003-3355-5179","position":10,"is_corresponding":false},{"id":68697,"name":"Tracy T. Batchelor","orcid":"0000-0001-7568-6607","position":11,"is_corresponding":false},{"id":699145,"name":"Omar Arnaout","orcid":"0000-0003-3890-8615","position":12,"is_corresponding":false},{"id":699935,"name":"Pier Paolo Peruzzi","orcid":null,"position":13,"is_corresponding":false},{"id":25289,"name":"E. Antonio Chiocca","orcid":"0000-0001-5183-1670","position":14,"is_corresponding":false},{"id":25295,"name":"David A. Reardon","orcid":"0000-0001-6674-0157","position":15,"is_corresponding":false},{"id":74588,"name":"David M. Meredith","orcid":"0000-0002-7054-8624","position":16,"is_corresponding":false},{"id":70392,"name":"Sandro Santagata","orcid":"0000-0002-7528-9668","position":17,"is_corresponding":false},{"id":1398,"name":"Rameen Beroukhim","orcid":"0000-0001-6303-3609","position":18,"is_corresponding":false},{"id":255214,"name":"Wenya Linda Bi","orcid":"0000-0002-4635-0247","position":19,"is_corresponding":false},{"id":1412,"name":"Keith L. Ligon","orcid":"0000-0002-7733-600X","position":20,"is_corresponding":false},{"id":25299,"name":"Patrick Y. Wen","orcid":"0000-0002-0774-7700","position":21,"is_corresponding":false},{"id":251890,"name":"Mary Jane Lim-Fat","orcid":"0000-0002-4317-5770","position":0,"is_corresponding":true}],"reference_count":40,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-18T23:46:11.334362Z","pmid":"34878541","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}